TL1 Postdoctoral Fellowship in Regenerative Medicine

Application Deadline: Jun. 30, 2024

We are delighted to announce that the BU CTSI will support one postdoctoral fellow as part the CTSI training program in Regenerative Medicine. If you are interested in this support please submit an application below. You can review the required materials by clicking "Visit our Website." 

Applications that are not complete will not be reviewed.

Please note any appointed 2024 Postdoctoral TL1 Trainees will receive

one year of support.

CTSA KL2 Virtual Visiting Scholars Grand Rounds:

“Optimizing Medicaid Managed Care to Improve Access, Quality,

and Clinical Outcomes for Patients with Gastrointestinal Cancers.”

Jun. 18, 2024 | 12– 1pm 

Lecturer: Aaron J. Dawes, MD, PhD, FACS, FASCRS

Assistant Professor, Colon and Rectal Surgery

Stanford University School of Medicine

Dr. Dawes is a colorectal surgeon and health services researcher who is passionate about improving cancer treatment and clinical outcomes for the most vulnerable patients.

His clinical expertise and earlier studies have sparked a significant interest in understanding how health-care system design influences cancer treatment delivery. He treats patients with colon, rectal, and anal malignancies on

a regular basis as part of a busy clinical practice at an NCI-Designated Cancer Center.

Dr. Dawes' firsthand experience as a caregiver allowed him to empathize with some of his patients struggling to access care, in part owing to difficulty navigating the Medicaid system, which is becoming increasingly complex and restrictive over time.

Please join the BU CTSI for the 2024 KL2 Virtual Visiting Scholars Grand Rounds, which aim to improve patient access and clinical outcomes.

NOT-CA-24-050

Notice of Special Interest (NOSI): Administrative Supplements to Encourage the Participation of SBIR/STTR Awardees in the Early Payor Feedback Program at the Center for Devices and Radiological Health (CDRH)

NOT-CA-24-058

Notice of Special Interest (NOSI): Administrative Supplement for Natural History

and Longitudinal Dynamics of Lung Nodules using the NLST dataset

NOT-CA-24-056

Notice of Special Interest (NOSI): Mechanisms

Driving Obesity

and Prostate Cancer Risk

National Cancer Institute (NCI)

NOT-OD-24-119

Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum

Office of Research

on Women's Health (ORWH)

PAR-25-021

NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)

NOT-DE-24-027

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)

National Institute

of Dental and Craniofacial Research (NIDCR)

NOT-DA-24-029

Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research

National Institute on Drug Abuse (NIDA)

RFA-NS-25-010

Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required)

RFA-NS-25-011

Functional Target Validation for Alzheimer's Disease-Related Dementias

National Institute

of Neurological Disorders and Stroke (NINDS)

ACTIV-1 Biospecimens and Clinical Data Available

We are pleased to announce the availability of ACTIV-1 biospecimens via the ACTIV Virtual Biorepository. This central web-based virtual biorepository

portal will provide an easily searchable inventory for residual biospecimens from the ACTIV therapeutic clinical trials. Investigators, including those from outside the ACTIV partnership, will be able to use the portal to request and receive these samples and associated metadata. In addition, ACTIV-1 clinical data is publicly available at AccessClinicalData@NIAID.

Clinical Research in Primary Care: A Public Workshop

Join us for this virtual workshop from 10:00 – 12:30 ET as we summarize findings from the listening sessions and speak to future initiatives from the NIH. We will be joined by NIH leadership including NIH Director Dr. Monica Bertagnolli, who will speak to her vision of how the network will benefit the health of all Americans.

Learn More